We have established partnerships with leading institutions such as Uppsala University Hospital and Linköping University Hospital. These collaborations focus on biobank studies and clinical trials, validating our technology. By integrating data from thousands of patients, we're uncovering correlations between immune types, disease severity, and treatment response.